Detalles de la búsqueda
1.
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.
Gastric Cancer
; 27(3): 558-570, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38308771
2.
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.
Future Oncol
; 19(11): 739-752, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919706
3.
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol
; 23(11): 1430-1440, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36244398
4.
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
Cancer
; 128(24): 4203-4212, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36259380
5.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet
; 398(10294): 27-40, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34102137
6.
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(8): 1126-1138, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237250
7.
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study.
Breast Cancer Res Treat
; 187(2): 467-476, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33748921
8.
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 19(1): 127-138, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29158011
9.
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
N Engl J Med
; 372(10): 923-32, 2015 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25738668
10.
Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
Strahlenther Onkol
; 191(8): 635-41, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25782685
11.
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study.
Thyroid
; 34(3): 347-359, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38062732
12.
Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab.
Pharmacogenet Genomics
; 22(1): 69-72, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22044939
13.
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.
N Engl J Med
; 360(14): 1408-17, 2009 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-19339720
14.
[Modern pharmacological therapy of breast cancer]. / Az emlorák korszeru gyógyszeres kezelése.
Orv Hetil
; 153(2): 56-65, 2012 Jan 15.
Artículo
en Húngaro
| MEDLINE | ID: mdl-22217685
15.
[Role of MRI in determining the therapy of rectal cancer]. / Az MR-vizsgálat szerepe a rectumcarcinomák terápiájának meghatározásában.
Magy Onkol
; 56(3): 179-86, 2012 Sep.
Artículo
en Húngaro
| MEDLINE | ID: mdl-23008826
16.
High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer.
Pathol Oncol Res
; 28: 1610315, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35570841
17.
Corrigendum: High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer.
Pathol Oncol Res
; 28: 1610658, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36277961
18.
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.
Clin Cancer Res
; 27(2): 504-512, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33082214
19.
SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.
BMC Cancer
; 10: 525, 2010 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-20920350
20.
Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer.
Pathol Oncol Res
; 26(4): 2683-2691, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32661836